<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Mol Vis</journal-id>
      <journal-id journal-id-type="publisher-id">MV</journal-id>
      <journal-title-group>
        <journal-title>Molecular Vision</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1090-0535</issn>
      <publisher>
        <publisher-name>Molecular Vision</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">21617748</article-id>
      <article-id pub-id-type="pmc">3102021</article-id>
      <article-id pub-id-type="publisher-id">138</article-id>
      <article-id pub-id-type="publisher-id">2010MOLVIS0270</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Asymmetric phenotype of Axenfeld-Rieger anomaly and aniridia associated with a novel <italic>PITX2</italic> mutation</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Law</surname>
            <given-names>Simon K.</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sami</surname>
            <given-names>Maha</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Piri</surname>
            <given-names>Natik</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Coleman</surname>
            <given-names>Anne L.</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Caprioli</surname>
            <given-names>Joseph</given-names>
          </name>
        </contrib>
        <aff id="aff1">Jules Stein Eye Institute, David Geffen School of Medicine, University of California, Los Angeles, CA</aff>
      </contrib-group>
      <author-notes>
        <corresp id="cor1">Correspondence to: Simon K. Law, M.D., 100 Stein Plaza #2-235, Jules Stein Eye Institute, Los Angeles, CA, 90095; Phone: (310) 794-1477; FAX: (310) 794-6616; email: <email xlink:href="law@jsei.ucla.edu">law@jsei.ucla.edu</email></corresp>
      </author-notes>
      <pub-date pub-type="collection">
        <year>2011</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>06</day>
        <month>5</month>
        <year>2011</year>
      </pub-date>
      <volume>17</volume>
      <fpage>1231</fpage>
      <lpage>1238</lpage>
      <history>
        <date date-type="received">
          <day>05</day>
          <month>7</month>
          <year>2010</year>
        </date>
        <date date-type="accepted">
          <day>01</day>
          <month>5</month>
          <year>2011</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2011 Molecular Vision.</copyright-statement>
        <copyright-year>2011</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/">
          <license-p>This is an open-access article distributed under the terms of the
        Creative Commons Attribution License, which permits unrestricted use,
        distribution, and reproduction in any medium, provided the original
        work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <sec>
          <title>Purpose</title>
          <p>To evaluate the asymmetry of the anterior segment phenotype between the two eyes of a patient with Axenfeld-Rieger syndrome (ARS).</p>
        </sec>
        <sec>
          <title>Methods</title>
          <p>The entire database of a tertiary glaucoma practice was screened for patients with ARS. The medical records of patients with ARS were reviewed. The clinical characteristics of ocular examination of the two eyes of each patient were recorded and compared. Dental and medical information were also reviewed where available. The anterior segment phenotype was tabulated to assess asymmetry. Asymmetric anterior segment characteristics of patients with ARS were compared with reported cases in the literature.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>Eight patients with ARS were identified from screening of more than 5,000 patients of a tertiary glaucoma practice. All patients had Axenfeld-Rieger anomaly in both eyes except one patient presented with an asymmetric phenotype of the anterior segment with features of Axenfeld-Rieger anomaly in one eye, but aniridia in the other eye. This patient had non-ocular findings including flat midface, hypodontia with lack of an upper incisor, and redundant periumbilical skin, typical for ARS. A heterozygous C&gt;T nucleotide substitution was identified in exon 4 of the pituitary homeobox 2 (<italic>PITX2</italic>) gene, resulting in the replacement of a glutamine codon (CAG) with a stop codon (TAG) at amino acid position 67. This mutation is denoted c.199C&gt;T at the cDNA level or p.Gln67Stop (or Q67X) at the protein level. Only three cases with asymmetric anterior segment phenotype between the two eyes of a patient with AGS have been reported in the literature.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>Variability in phenotype may occur between the two eyes of an individual affected by ARS. The current case undermines the advantage of genetic testing to correctly diagnose a rare disease.</p>
        </sec>
      </abstract>
      <custom-meta-group>
        <custom-meta>
          <meta-name>GalleyStatus</meta-name>
          <meta-value>Export to XML</meta-value>
        </custom-meta>
        <custom-meta>
          <meta-name>corr-author</meta-name>
          <meta-value>Law</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>Introduction</title>
      <p>Axenfeld-Rieger syndrome (ARS) is characterized by a variable combination of anterior segment dysgenesis, dental anomalies, and umbilical hernia. Reported anterior segment features in ARS include iris stromal hypoplasia (poor development of the anterior stroma of the iris), iridogoniodysgenesis (hypoplastic iris with abnormal &#x201C;wooly&#x201D; iridocorneal angle tissue), corectopia (eccentric pupil), polycoria (iris tears), ectropion uveae (eversion of the pupillary margin), posterior embryotoxon (prominent and centrally displaced Schwalbe&#x2019;s line), and iris strands bridging the iridocorneal angle to the trabecular meshwork [<xref ref-type="bibr" rid="r1">1</xref>]. About half of the patients develop secondary angle closure glaucoma [<xref ref-type="bibr" rid="r2">2</xref>]. Although there are a few cases of an asymmetric phenotype between fellow eyes of a patient with ARS, similar anterior segment characteristics of fellow eyes are the usual presentation [<xref ref-type="bibr" rid="r3">3</xref>,<xref ref-type="bibr" rid="r4">4</xref>]. The purpose of this study was to evaluate the asymmetry of phenotype of the anterior segment between the two eyes of a patient with Axenfeld-Rieger syndrome (ARS), and present a case of ARS with asymmetric anterior segment phenotype and the associated genotype.</p>
    </sec>
    <sec sec-type="methods">
      <title>Methods</title>
      <p>The Institutional Review Board at University of California Los Angeles, Los Angeles, CA approved the current study and it was performed in accordance with the Declaration of Helsinki. The entire database of a tertiary glaucoma practice was screened to identify patients with ARS. The medical records of patients with ARS were retrospective reviewed. The medical data collected included the eye examination, and dental and medical records. The clinical characteristics of the two eyes of each patient with ARS were recorded and compared. The anterior segment phenotype was tabulated to assess asymmetry. A literature review of asymmetric phenotypes of the anterior segment of patients with ARS was conducted.</p>
      <p>In review of the preliminary data collected, one patient had markedly asymmetric anterior segment phenotype between the two eyes. Genetic testing was ordered for this patient. PCR and DNA sequencing was performed by GeneDx (Gaithersburg, MD). Primer sequences and PCR conditions cannot be disclosed here since GeneDx has proprietary rights on this information.</p>
    </sec>
    <sec sec-type="results">
      <title>Results</title>
      <p>Eight patients with ARS were identified from screening the medical records of more than five thousand patients of a tertiary glaucoma practice. All patients had symmetric Axenfeld anomaly and/or Rieger anomaly in both eyes, except for one patient who presented with an asymmetric phenotype of the anterior segment with Axenfeld-Rieger anomaly in one eye, but aniridia in the other eye. <xref ref-type="table" rid="t1">Table 1</xref> summarizes the clinical characteristics of the ocular examination of the eight patients. Except for the case (Patient MA) with a markedly asymmetric phenotype between the two eyes, the rest of the patients had iris stromal hypoplasia, corectopia, polycoria, ectropion uveae, and posterior embryotoxon in both eyes. Seven of the eight patients had glaucoma in both eyes. One patient who had mild Axenfeld anomaly had no glaucoma in either eye. Six patients had central corneal thickness (CCT) measured for at least one eye. The average CCT (standard deviation) of the right eye was 602 (40) microns and left eye was 613 (57) microns.</p>
      <table-wrap id="t1" position="float">
        <label>Table 1</label>
        <caption>
          <title>Clinical presentations of the two eyes of an individual with Axenfeld-Rieger syndrome.</title>
        </caption>
        <table frame="hsides" rules="groups">
          <col width="47" span="1"/>
          <col width="38" span="1"/>
          <col width="46" span="1"/>
          <col width="64" span="1"/>
          <col width="64" span="1"/>
          <col width="72" span="1"/>
          <col width="63" span="1"/>
          <col width="68" span="1"/>
          <col width="84" span="1"/>
          <col width="84" span="1"/>
          <thead>
            <tr>
              <th valign="top" align="center" scope="col" rowspan="1" colspan="1">
                <bold>Patient</bold>
              </th>
              <th valign="top" align="center" scope="col" rowspan="1" colspan="1">
                <bold>Year of Birth</bold>
              </th>
              <th valign="top" align="center" scope="col" rowspan="1" colspan="1">
                <bold>Sex</bold>
              </th>
              <th valign="top" align="center" scope="col" rowspan="1" colspan="1">
                <bold>Anterior segment phenotype of first eye</bold>
              </th>
              <th valign="top" align="center" scope="col" rowspan="1" colspan="1">
                <bold>Anterior segment phenotype of second eye</bold>
              </th>
              <th valign="top" align="center" scope="col" rowspan="1" colspan="1">
                <bold>Additional ocular findings</bold>
              </th>
              <th valign="top" align="center" scope="col" rowspan="1" colspan="1">
                <bold>Eye with Glaucoma</bold>
              </th>
              <th valign="top" align="center" scope="col" rowspan="1" colspan="1">
                <bold>Central corneal thickness (Right/Left eye) in micron</bold>
              </th>
              <th valign="top" align="center" scope="col" rowspan="1" colspan="1">
                <bold>Dental Abnormalities</bold>
              </th>
              <th valign="top" align="center" scope="col" rowspan="1" colspan="1">
                <bold>Umbilical Abnormalities</bold>
              </th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td valign="top" align="center" scope="row" rowspan="1" colspan="1">G.G.<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">1980<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">Male<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">Axenfeld &amp; Rieger anomalies<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">Axenfeld &amp; Rieger anomalies<hr/></td>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <hr/>
              </td>
              <td valign="top" align="center" rowspan="1" colspan="1">Both eyes<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">560 / 545<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">Unknown<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">Unknown<hr/></td>
            </tr>
            <tr>
              <td valign="top" align="center" scope="row" rowspan="1" colspan="1">K.M.<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">1980<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">Male<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">Rieger anomaly<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">Rieger anomaly<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">Optic nerve coloboma (right eye)<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">Both eyes<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">616 / 616<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">Unknown<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">Unknown<hr/></td>
            </tr>
            <tr>
              <td valign="top" align="center" scope="row" rowspan="1" colspan="1">J.B.*<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">1990<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">Female<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">Axenfeld anomaly<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">Axenfeld anomaly<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">Microcornea and scleral thinning (both eyes)<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">None<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">576 / 606<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">Presence<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">Presence<hr/></td>
            </tr>
            <tr>
              <td valign="top" align="center" scope="row" rowspan="1" colspan="1">M.B.*<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">1960<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">Female<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">Axenfeld &amp; Rieger anomalies<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">Axenfeld &amp; Rieger anomalies<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">Corneal scar and scleral thinning (left eye)<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">Both eyes<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">571 / left corneal scar<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">Presence<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">Unknown<hr/></td>
            </tr>
            <tr>
              <td valign="top" align="center" scope="row" rowspan="1" colspan="1">A.C.<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">1954<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">Male<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">Axenfeld &amp; Rieger anomalies<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">Axenfeld &amp; Rieger anomalies<hr/></td>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <hr/>
              </td>
              <td valign="top" align="center" rowspan="1" colspan="1">Both eyes<hr/></td>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <hr/>
              </td>
              <td valign="top" align="center" rowspan="1" colspan="1">Unknown<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">Unknown<hr/></td>
            </tr>
            <tr>
              <td valign="top" align="center" scope="row" rowspan="1" colspan="1">A.M.<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">2009<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">Female<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">Rieger anomaly<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">Rieger anomaly<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">Cataract and corneal scar (both eyes)<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">Both eyes<hr/></td>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <hr/>
              </td>
              <td valign="top" align="center" rowspan="1" colspan="1">Unknown<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">Absence<hr/></td>
            </tr>
            <tr>
              <td valign="top" align="center" scope="row" rowspan="1" colspan="1">H.L.<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">1996<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">Male<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">Axenfeld &amp; Rieger anomalies<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">Axenfeld &amp; Rieger anomalies<hr/></td>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <hr/>
              </td>
              <td valign="top" align="center" rowspan="1" colspan="1">Both eyes<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">626 / not measurable<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">Presence<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">Presence<hr/></td>
            </tr>
            <tr>
              <td valign="top" align="center" scope="row" rowspan="1" colspan="1">M.A.</td>
              <td valign="top" align="center" rowspan="1" colspan="1">2003<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">Female</td>
              <td valign="top" align="center" rowspan="1" colspan="1">Axenfeld &amp; Rieger anomalies</td>
              <td valign="top" align="center" rowspan="1" colspan="1">Aniridia</td>
              <td valign="top" align="left" rowspan="1" colspan="1"/>
              <td valign="top" align="center" rowspan="1" colspan="1">Both eyes</td>
              <td valign="top" align="center" rowspan="1" colspan="1">664 / 683</td>
              <td valign="top" align="center" rowspan="1" colspan="1">Presence</td>
              <td valign="top" align="center" rowspan="1" colspan="1">Presence</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <p>Signs of Axenfeld anomaly include: prominent schwalbe line, iris adhesion to cornea and trabecular meshwork. Signs of Rieger anomaly include: iris hypoplasia, correctopia or polycoria, ectropion uveae. *J.B. and M.B. had a mother-and-son relationship</p>
        </table-wrap-foot>
      </table-wrap>
      <p>In this retrospective review, the seven patients that had bilateral ocular findings typical for ARS received no genetic work up. However, the patient with the unusual asymmetric phenotype with features of Axenfeld-Rieger anomaly in one eye and aniridia in the other eye posed a diagnostic uncertainty and systemic and genetic evaluation were performed. Details of the clinical presentation and evaluation of this patient are reported as follows.</p>
      <sec>
        <title>Case (Patient M.A.)</title>
        <p>The patient was referred to our institute when she was four years old with an uncertain diagnosis of ARS versus aniridia. Shortly before the referral, she was found to have an increased intraocular pressure (IOP) in both eyes: 27&#xA0;mmHg in the right and 46&#xA0;mmHg in the left, and was started on glaucoma medications. When she was using timolol and dorzolamide as fixed combination and bimatoprost eye drops in both eyes, the IOP measured by Goldmann tonometry was 14&#xA0;mmHg in the right and 32 in the left. Her spectacle-corrected vision was 20/80 in the right and 20/40 in the left, with moderate hyperopia in the right and mild myopia in the left. The right eye was amblyopic, and was undergoing occlusion therapy. She has no strabismus or nystagmus. Slit lamp examination of the right eye revealed polycoria, adhesion of iris strands to the peripheral cornea, and posterior embryotoxon. (<xref ref-type="fig" rid="f1">Figure 1</xref>) Examination of the left eye revealed a small iris stub resembling aniridia, and a similar appearance was noted on an old photograph taken when she was 3 months old (<xref ref-type="fig" rid="f2">Figure 2</xref> and <xref ref-type="fig" rid="f3">Figure 3</xref>).Corneal pachymetry was 664 microns in the right and 683 microns in the left. The horizontal corneal diameter measured 11&#xA0;mm in both eyes. Axial length by ultrasonic measurement was 21.78&#xA0;mm in the right eye and 24.46&#xA0;mm in the left eye. Gonioscopy revealed extensive iris strands bridging the iridocorneal angle to the trabecular meshwork in the right and complete angle closure by the stub of the iris in the left. Optic disc examination revealed a cup/disc ratio of 0.30 in the right eye and 0.95 in the left, and there was no retinal pathology (<xref ref-type="fig" rid="f4">Figure 4</xref> and <xref ref-type="fig" rid="f5">Figure 5</xref>). Further physical examination revealed a flat midface, hypodontia with lack of an upper incisor, and redundant periumbilical skin (<xref ref-type="fig" rid="f6">Figure 6</xref> and <xref ref-type="fig" rid="f7">Figure 7</xref>). Ultrasonic examination of kidneys was normal and there was no cardiac abnormality. She has normal intelligence. Other family members including both parents and a younger brother were examined and no similar anomaly was noted. However, the maternal uncle has Russell-Silver syndrome and was not available to be examined.</p>
        <fig id="f1" fig-type="figure" position="float">
          <label>Figure 1</label>
          <caption>
            <p>Anterior segment photograph of the right eye shows polycoria, adhesion of iris strands with peripheral cornea, and posterior emblyotoxon.</p>
          </caption>
          <graphic xlink:href="mv-v17-1231-f1"/>
        </fig>
        <fig id="f2" fig-type="figure" position="float">
          <label>Figure 2</label>
          <caption>
            <p>Anterior segment photograph of the left eye shows aniridia.</p>
          </caption>
          <graphic xlink:href="mv-v17-1231-f2"/>
        </fig>
        <fig id="f3" fig-type="figure" position="float">
          <label>Figure 3</label>
          <caption>
            <p>Old photograph of patient when she was 3 months old shows similar anterior segment appearance.</p>
          </caption>
          <graphic xlink:href="mv-v17-1231-f3"/>
        </fig>
        <fig id="f4" fig-type="figure" position="float">
          <label>Figure 4</label>
          <caption>
            <p>Optic disc photograph of the right eye shows normal neural rim.</p>
          </caption>
          <graphic xlink:href="mv-v17-1231-f4"/>
        </fig>
        <fig id="f5" fig-type="figure" position="float">
          <label>Figure 5</label>
          <caption>
            <p>Optic disc photograph of the left eye shows severe loss of neural rim.</p>
          </caption>
          <graphic xlink:href="mv-v17-1231-f5"/>
        </fig>
        <fig id="f6" fig-type="figure" position="float">
          <label>Figure 6</label>
          <caption>
            <p>Facial photograph of patient shows flat midface and hypodontia lacking of an upper incisor.</p>
          </caption>
          <graphic xlink:href="mv-v17-1231-f6"/>
        </fig>
        <fig id="f7" fig-type="figure" position="float">
          <label>Figure 7</label>
          <caption>
            <p>Abdominal photograph of patient shows redundant periumbilical skin.</p>
          </caption>
          <graphic xlink:href="mv-v17-1231-f7"/>
        </fig>
        <p>Parents of the patient underwent genetic counseling and consented to the genetic testing of the patient. Genomic DNA from the patient&#x2019;s blood sample was PCR-amplified and screened for mutations in pituitary homeobox 2 (<italic>PITX2</italic>), forkhead box C1 (<italic>FOXC1</italic>), and paired box 6 (<italic>PAX6</italic>) genes that are known to be associated with ARS. Coding exons of <italic>PITX2b</italic> (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_153426">NM_153426</ext-link>) were analyzed in this study. A heterozygous C&gt;T nucleotide substitution (a nonsense mutation) was identified in exon 4 of <italic>PITX2</italic>, resulting in the replacement of a glutamine codon (CAG) with a stop codon (TAG) at amino acid position 67. This mutation is denoted c.199C&gt;T at the cDNA level or p.Gln67Stop (or Q67X) at the protein level (<xref ref-type="fig" rid="f8">Figure 8</xref>). No sequence alterations were detected in <italic>FOXC1</italic> and <italic>PAX6</italic>.</p>
        <fig id="f8" fig-type="figure" position="float">
          <label>Figure 8</label>
          <caption>
            <p>Sequencing analysis of the Axenfeld-Rieger syndrome patient&#x2019;s <italic>PITX2</italic> gene with the C&gt;T mutation.</p>
          </caption>
          <graphic xlink:href="mv-v17-1231-f8"/>
        </fig>
        <p>She subsequently received a tube shunt procedure in the left eye and an additional tube shunt procedure 2 years later with pressure of the left eye controlled at 20&#x2013;22&#xA0;mmHg on minimum topical medication.</p>
      </sec>
      <sec>
        <title>Literature review</title>
        <p>A literature review identified asymmetric phenotypes of the anterior segment in three patients with ARS (<xref ref-type="table" rid="t2">Table 2</xref>). In 1883, Vossius [<xref ref-type="bibr" rid="r5">5</xref>] described a nine-year-old girl with bilateral iris defects associated with dental anomalies. One eye had an ectopic pupil (corectopia) with full-thickness iris stromal defects (polycoria) while the fellow eye had a near-total absence of iris tissue (aniridia). The other two patients were reported by Perveen et al. [<xref ref-type="bibr" rid="r4">4</xref>] in 2000. These two patients had unilateral Peters anomaly in one eye but the other eye had Rieger anomaly or iris hypoplasia [<xref ref-type="bibr" rid="r4">4</xref>].</p>
        <table-wrap id="t2" position="float">
          <label>Table 2</label>
          <caption>
            <title>Clinical presentations and mutations of cases with asymmetric anterior segment phenotype between the two eyes of an individual with Axenfeld-Rieger syndrome [<xref ref-type="bibr" rid="r1">1</xref>,<xref ref-type="bibr" rid="r4">4</xref>,<xref ref-type="bibr" rid="r5">5</xref>].</title>
          </caption>
          <table frame="hsides" rules="groups">
            <col width="62" span="1"/>
            <col width="64" span="1"/>
            <col width="71" span="1"/>
            <col width="65" span="1"/>
            <col width="63" span="1"/>
            <col width="81" span="1"/>
            <col width="81" span="1"/>
            <col width="149" span="1"/>
            <thead>
              <tr>
                <th valign="top" align="center" scope="col" rowspan="1" colspan="1">
                  <bold>Reference</bold>
                </th>
                <th valign="top" align="center" scope="col" rowspan="1" colspan="1">
                  <bold>Anterior segment phenotype of first eye</bold>
                </th>
                <th valign="top" align="center" scope="col" rowspan="1" colspan="1">
                  <bold>Anterior segment phenotype of second eye</bold>
                </th>
                <th valign="top" align="center" scope="col" rowspan="1" colspan="1">
                  <bold>Additional ocular findings</bold>
                </th>
                <th valign="top" align="center" scope="col" rowspan="1" colspan="1">
                  <bold>Glaucoma</bold>
                </th>
                <th valign="top" align="center" scope="col" rowspan="1" colspan="1">
                  <bold>Dental abnormalities</bold>
                </th>
                <th valign="top" align="center" scope="col" rowspan="1" colspan="1">
                  <bold>Umbilical abnormalities</bold>
                </th>
                <th valign="top" align="center" scope="col" rowspan="1" colspan="1">
                  <bold>Mutation</bold>
                </th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td valign="top" align="center" scope="row" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="r5">5</xref>]<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">Near total absence of iris (aniridia)<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">full thickness iris stromal defects<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">Unknown<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">Unknown<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">Unknown<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">Unknown<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">Unknown<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="center" scope="row" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="r4">4</xref>]<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">Peters anomaly<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">Rieger anomaly, anterior polar cataract<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">Mild unilateral foveal hypoplasia<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">Absence<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">Presence<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">Presence<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">PITX2 Ivs 3 (&#x2212;2); A&gt;T<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="center" scope="row" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="r4">4</xref>]<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">Axenfeld anomaly, iris hypoplasia<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">Peters anomaly<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">None<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">Absence<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">Presence<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">Unknown<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">PITX2 C ins 1083<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="center" scope="row" rowspan="1" colspan="1">Current patient</td>
                <td valign="top" align="center" rowspan="1" colspan="1">Rieger anomaly, Axenfeld anomaly</td>
                <td valign="top" align="center" rowspan="1" colspan="1">Aniridia</td>
                <td valign="top" align="center" rowspan="1" colspan="1">None</td>
                <td valign="top" align="center" rowspan="1" colspan="1">Presence</td>
                <td valign="top" align="center" rowspan="1" colspan="1">Presence</td>
                <td valign="top" align="center" rowspan="1" colspan="1">Presence</td>
                <td valign="top" align="center" rowspan="1" colspan="1">PITX2 c. 199 C&gt;T (Q67X)</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <p>Signs of Axenfeld anomaly include: prominent schwalbe line, iris adhesion to cornea and trabecular meshwork. Signs of Rieger anomaly include: iris hypoplasia, correctopia or polycoria, ectropion uveae. Signs of Peters anomaly were not explained in the report by Perveen et al. [<xref ref-type="bibr" rid="r4">4</xref>].</p>
          </table-wrap-foot>
        </table-wrap>
      </sec>
    </sec>
    <sec sec-type="discussion">
      <title>Discussion</title>
      <p>Although tremendous variability in phenotype within a single family with ARS has been observed, phenotypes between the two eyes of an affected individual are usually similar [<xref ref-type="bibr" rid="r1">1</xref>]. Seven of the eight patients with ARS in our tertiary glaucoma practice presented with a similar anterior segment phenotype between the two eyes. However, one patient presented with anterior segment features of Axenfeld-Rieger anomaly in one eye, and aniridia in the other eye. In 1883, Vossius [<xref ref-type="bibr" rid="r5">5</xref>] described a nine-year-old girl with Rieger anomaly in one eye including an ectopic pupil with full-thickness iris stromal defects, while the fellow eye had a near-total absence of iris tissue (aniridia). To our knowledge, description of the asymmetric phenotype of Axenfeld-Rieger anomaly in one eye and severe iris hypoplasia resembling aniridia in the other eye has not been previously reported.</p>
      <p>It is known that mutations in the transcription factor <italic>PITX2</italic> and <italic>FOXC1</italic> genes lead to ARS, while mutations of the <italic>PAX6</italic> gene underlies many cases of aniridia [<xref ref-type="bibr" rid="r6">6</xref>,<xref ref-type="bibr" rid="r7">7</xref>]. However, Henkind and associates [<xref ref-type="bibr" rid="r8">8</xref>] described a family with ARS that included two members who appeared to have aniridia. In addition, cases of ARS have been described associated with a deletion of <italic>PAX6</italic> [<xref ref-type="bibr" rid="r6">6</xref>,<xref ref-type="bibr" rid="r9">9</xref>,<xref ref-type="bibr" rid="r10">10</xref>], and cases of bilateral aniridia with proven <italic>PITX2</italic> and <italic>FOXC1</italic> mutations [<xref ref-type="bibr" rid="r4">4</xref>,<xref ref-type="bibr" rid="r11">11</xref>]. Because of the mixed anterior segment anomalies between the two eyes of this patient and the association of Wilm&#x2019;s tumor in sporadic cases of aniridia, genetic testing was conducted for <italic>PITX2</italic>, <italic>FOXC1</italic>, and <italic>PAX6</italic>  [<xref ref-type="bibr" rid="r6">6</xref>]. The nonsense mutation, Q67X, in exon 4 of <italic>PITX2</italic> identified has not previously been reported, to our knowledge [<xref ref-type="bibr" rid="r7">7</xref>].</p>
      <p><italic>PITX2</italic> mutations are primarily responsible for ARS but have also been associated with Peters anomaly, iris hypoplasia/iridogoniodysgenesis syndrome, aniridia, and ring dermoid of the cornea [<xref ref-type="bibr" rid="r4">4</xref>,<xref ref-type="bibr" rid="r7">7</xref>,<xref ref-type="bibr" rid="r12">12</xref>]. Intragenic mutations of <italic>PITX2</italic> have been described in more than 40 ARS patients to date and include missense, nonsense, splice-site mutations, and deletions/insertions/duplications. There is no apparent correlation between the mutation location in <italic>PITX2</italic> and the severity of the clinical phenotype. However, the characterization of several missense mutations indicates that the severity of the phenotype can be correlated to the remaining function of the mutant PITX2. In heterozygotes, the function of one wild-type PITX2 allele alone results in the severe ARS form. Contribution of the mutant allele would result in the milder iris hypolasia or iridogoniodysgenesis syndrome forms, depending on the degree of residual activity [<xref ref-type="bibr" rid="r13">13</xref>]. A nonsense mutation in <italic>PITX2</italic> found in patient M.A. is predicted to result in degradation of the mutant mRNA through the nonsense-mediated decay pathway that prevent the synthesis of the truncated protein [<xref ref-type="bibr" rid="r14">14</xref>]. Even if the truncated 66 amino acid (aa) long protein is synthesized and stable, it would be shorter than the native protein by 251 aa and would lack helix 2 and helix 3/4 of the DNA binding homeodomain involved in transcriptional regulation and the OAR domain in the COOH-terminal end that has been proposed to increase the DNA binding and transcriptional activity of PITX2 during development [<xref ref-type="bibr" rid="r15">15</xref>]. The absence of clinical and genetic abnormalities in other family members suggests that this may be a de novo genomic alteration [<xref ref-type="bibr" rid="r3">3</xref>]. Finally, since PITX2 is known to inhibit FOXC1 activity [<xref ref-type="bibr" rid="r16">16</xref>], the mechanism for PITX2-related severity of the ocular phenotype in this patient may be the simultaneous consequence of PITX2 haploinsufficiency and a gain of function of FOXC1.</p>
      <p>Mutations of <italic>PITX2</italic> are usually associated with full-spectrum ARS phenotypes that include both ocular and nonocular features, as in patient M.A [<xref ref-type="bibr" rid="r1">1</xref>]. Intriguingly, PITX2 is also involved in left-right polarity determination, yet asymmetry defects are not a usual feature of ARS [<xref ref-type="bibr" rid="r3">3</xref>,<xref ref-type="bibr" rid="r4">4</xref>,<xref ref-type="bibr" rid="r17">17</xref>]. Iris abnormalities are usually stationary, but rarely have been demonstrated to change over time [<xref ref-type="bibr" rid="r18">18</xref>]. In our patient, the aniridia in the left eye appears to remain unchanged since infancy by comparison with old photographs. Aniridia is a panocular disease with associated ocular and visual defects such as corneal opacification, cataract, foveal dysplasia, optic nerve hypoplasia, and nystagmus, but none of which is found in this patient [<xref ref-type="bibr" rid="r6">6</xref>]. It is possible that the different phenotypes of iris abnormality in the two eyes of this patient fall within a spectrum of iris defect in ARS.</p>
      <p>The major clinical concern in ARS is the risk of developing sight-threatening glaucoma, which is estimated to occur in 50% of the patients [<xref ref-type="bibr" rid="r1">1</xref>,<xref ref-type="bibr" rid="r2">2</xref>]. Although physical occlusion of the angle structure is not prerequisite for elevated IOP and glaucoma in ARS, the severity of glaucoma does correlate with the level of iris insertion into the angle [<xref ref-type="bibr" rid="r2">2</xref>]. In the seven patients of this series who had glaucoma in both eyes, the eye with more extensive areas of angle closure presented with higher IOP and was more resistant to medical and surgical management.</p>
      <p>Patients in this series had a thicker central cornea compared to normal adults, and a thick central cornea is associated with artificially higher IOP estimation by applanation. Pachymetry of patients with ARS is rarely reported in the literature. In mouse models with overexpressing PITX2A isoform in the cornea, corneal hypertrophy was noted together with iridocorneal adhesion, gray and tearing eyes, and severe apoptosis-associated retinal degeneration [<xref ref-type="bibr" rid="r19">19</xref>]. In human with ARS-causing PITX2 mutation, V45L, elevated transactivating properties in cell culture were found [<xref ref-type="bibr" rid="r20">20</xref>]. It is suggestive that increased as well as reduced PITX2 activities are deleterious during development [<xref ref-type="bibr" rid="r17">17</xref>]. Further functional studies may clarify if the novel mutation of PITX2 found in our patient is associated with a gain-of-function leading to an increase of thickness of the cornea.</p>
      <p>In summary, although phenotypic presentation of ARS is highly variable within a single family, only a few cases in the literature had different phenotypes between the two eyes of an individual. We presented a case of an asymmetric phenotype of Axenfeld-Rieger anomaly in one eye and aniridia in another of a patient with a novel nonsense point mutation of <italic>PITX2</italic>. The current case undermines the variability in phenotype even between the two eyes of an individual affected by ARS and the advantage of genetic testing in correctly diagnosing a rare disease.</p>
    </sec>
  </body>
  <back>
    <ack>
      <title>Acknowledgments</title>
      <p>This study is supported in part by an unrestricted grant from Research to Prevent Blindness. No author has a proprietary interest in the development or marketing of any of the products or devices mentioned in the study.</p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="r1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Alward</surname>
              <given-names>WL</given-names>
            </name>
          </person-group>
          <article-title>Axenfeld-Rieger syndrome in the age of molecular genetics.</article-title>
          <source>Am J Ophthalmol</source>
          <year>2000</year>
          <volume>130</volume>
          <fpage>107</fpage>
          <lpage>15</lpage>
          <pub-id pub-id-type="pmid">11004268</pub-id>
        </element-citation>
      </ref>
      <ref id="r2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shields</surname>
              <given-names>MB</given-names>
            </name>
          </person-group>
          <article-title>Axenfeld-Rieger syndrome: a theory of mechanism and distinctions from the iridocorneal endothelial syndrome.</article-title>
          <source>Trans Am Ophthalmol Soc</source>
          <year>1983</year>
          <volume>81</volume>
          <fpage>736</fpage>
          <lpage>84</lpage>
          <pub-id pub-id-type="pmid">6676983</pub-id>
        </element-citation>
      </ref>
      <ref id="r3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hjalt</surname>
              <given-names>TA</given-names>
            </name>
            <name>
              <surname>Semina</surname>
              <given-names>EV</given-names>
            </name>
          </person-group>
          <article-title>Current molecular understanding of Axenfeld-Rieger syndrome</article-title>
          <source>Expert Rev Mol Med</source>
          <year>2005</year>
          <volume>7</volume>
          <fpage>1</fpage>
          <lpage>17</lpage>
          <pub-id pub-id-type="pmid">16274491</pub-id>
        </element-citation>
      </ref>
      <ref id="r4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Perveen</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Lloyd</surname>
              <given-names>IC</given-names>
            </name>
            <name>
              <surname>Clayton-Smith</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Churchill</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>van Heyningen</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Hanson</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Taylor</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>McKeown</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Super</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kerr</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Winter</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Black</surname>
              <given-names>GC</given-names>
            </name>
          </person-group>
          <article-title>Phenotypic variability and asymmetry of Rieger syndrome associated with PITX2 mutations.</article-title>
          <source>Invest Ophthalmol Vis Sci</source>
          <year>2000</year>
          <volume>41</volume>
          <fpage>2456</fpage>
          <lpage>60</lpage>
          <pub-id pub-id-type="pmid">10937553</pub-id>
        </element-citation>
      </ref>
      <ref id="r5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vossius</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Congenitale abnormalien der iris.</article-title>
          <source>Klin Monatsbl Augenheilkd</source>
          <year>1883</year>
          <volume>21</volume>
          <fpage>233</fpage>
          <lpage>7</lpage>
        </element-citation>
      </ref>
      <ref id="r6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Prosser</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>van Heyningen</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <article-title>PAX6 mutations reviewed.</article-title>
          <source>Hum Mutat</source>
          <year>1998</year>
          <volume>11</volume>
          <fpage>93</fpage>
          <lpage>108</lpage>
          <pub-id pub-id-type="pmid">9482572</pub-id>
        </element-citation>
      </ref>
      <ref id="r7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>T&#xFC;mer</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Bach-Holm</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Axenfeld-Rieger syndrome and spectrum of PITX2 and FOXC1 mutations.</article-title>
          <source>Eur J Hum Genet</source>
          <year>2009</year>
          <volume>17</volume>
          <fpage>1527</fpage>
          <lpage>39</lpage>
          <pub-id pub-id-type="pmid">19513095</pub-id>
        </element-citation>
      </ref>
      <ref id="r8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Henkind</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Siegel</surname>
              <given-names>IM</given-names>
            </name>
            <name>
              <surname>Carr</surname>
              <given-names>RE</given-names>
            </name>
          </person-group>
          <article-title>Mesodermal dysgenesis of the anterior segment: Rieger&#x2019;s anomaly.</article-title>
          <source>Arch Ophthalmol</source>
          <year>1965</year>
          <volume>73</volume>
          <fpage>810</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="pmid">14302514</pub-id>
        </element-citation>
      </ref>
      <ref id="r9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Riise</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Storhaug</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Brondum-Nielsen</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Rieger syndrome is associated with PAX6.</article-title>
          <source>Acta Ophthalmol Scand</source>
          <year>2001</year>
          <volume>79</volume>
          <fpage>201</fpage>
          <lpage>3</lpage>
          <pub-id pub-id-type="pmid">11284764</pub-id>
        </element-citation>
      </ref>
      <ref id="r10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hanson</surname>
              <given-names>IM</given-names>
            </name>
          </person-group>
          <article-title>PAX6 and congenital eye malformation.</article-title>
          <source>Pediatr Res</source>
          <year>2003</year>
          <volume>54</volume>
          <fpage>791</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="pmid">14561779</pub-id>
        </element-citation>
      </ref>
      <ref id="r11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ito</surname>
              <given-names>YA</given-names>
            </name>
            <name>
              <surname>Footz</surname>
              <given-names>TK</given-names>
            </name>
            <name>
              <surname>Berry</surname>
              <given-names>FB</given-names>
            </name>
            <name>
              <surname>Mirzayans</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Khan</surname>
              <given-names>AO</given-names>
            </name>
            <name>
              <surname>Walter</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <article-title>Severe molecular defects of a novel FOXC1 W152G mutation result in aniridia.</article-title>
          <source>Invest Ophthalmol Vis Sci</source>
          <year>2009</year>
          <volume>50</volume>
          <fpage>3573</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">19279310</pub-id>
        </element-citation>
      </ref>
      <ref id="r12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Alward</surname>
              <given-names>WL</given-names>
            </name>
            <name>
              <surname>Semina</surname>
              <given-names>EV</given-names>
            </name>
            <name>
              <surname>Kalenak</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>H&#xE9;on</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Sheth</surname>
              <given-names>BP</given-names>
            </name>
            <name>
              <surname>Stone</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Murray</surname>
              <given-names>JC</given-names>
            </name>
          </person-group>
          <article-title>Autosomal dominant iris hypoplasia is caused by a mutation in the Rieger syndrome (RIEG/PITX2) gene.</article-title>
          <source>Am J Ophthalmol</source>
          <year>1998</year>
          <volume>125</volume>
          <fpage>98</fpage>
          <lpage>100</lpage>
          <pub-id pub-id-type="pmid">9437321</pub-id>
        </element-citation>
      </ref>
      <ref id="r13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kozlowski</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Walter</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <article-title>Variation in residual PITX2 activity underlies the phenotypic spectrum of anterior segment developmental disorders.</article-title>
          <source>Hum Mol Genet</source>
          <year>2000</year>
          <volume>9</volume>
          <fpage>2131</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">10958652</pub-id>
        </element-citation>
      </ref>
      <ref id="r14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Culbertson</surname>
              <given-names>MR</given-names>
            </name>
          </person-group>
          <article-title>RNA surveillance. Unforeseen consequences for gene expression, inherited genetic disorders and cancer.</article-title>
          <source>Trends Genet</source>
          <year>1999</year>
          <volume>15</volume>
          <fpage>74</fpage>
          <lpage>80</lpage>
          <pub-id pub-id-type="pmid">10098411</pub-id>
        </element-citation>
      </ref>
      <ref id="r15">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Amendt</surname>
              <given-names>BA</given-names>
            </name>
            <name>
              <surname>Semina</surname>
              <given-names>EV</given-names>
            </name>
            <name>
              <surname>Alward</surname>
              <given-names>WL</given-names>
            </name>
          </person-group>
          <article-title>Rieger syndrome: a clinical, molecular, and biochemical analysis.</article-title>
          <source>Cell Mol Life Sci</source>
          <year>2000</year>
          <volume>57</volume>
          <fpage>1652</fpage>
          <lpage>66</lpage>
          <pub-id pub-id-type="pmid">11092457</pub-id>
        </element-citation>
      </ref>
      <ref id="r16">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Berry</surname>
              <given-names>FB</given-names>
            </name>
            <name>
              <surname>Lines</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Oas</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Footz</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Underhill</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Gage</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Walter</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <article-title>Functional interactions between FOXC1 and PITX2 underlie the sensitivity to FOXC1 gene dose in Axenfeld-Rieger syndrome and anterior segment dysgenesis.</article-title>
          <source>Hum Mol Genet</source>
          <year>2006</year>
          <volume>15</volume>
          <fpage>905</fpage>
          <lpage>19</lpage>
          <pub-id pub-id-type="pmid">16449236</pub-id>
        </element-citation>
      </ref>
      <ref id="r17">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lines</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Kozlowski</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Walter</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <article-title>Molecular genetics of Axenfeld-Rieger malformations.</article-title>
          <source>Hum Mol Genet</source>
          <year>2002</year>
          <volume>11</volume>
          <fpage>1177</fpage>
          <lpage>84</lpage>
          <pub-id pub-id-type="pmid">12015277</pub-id>
        </element-citation>
      </ref>
      <ref id="r18">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Judisch</surname>
              <given-names>GF</given-names>
            </name>
            <name>
              <surname>Phelps</surname>
              <given-names>CD</given-names>
            </name>
            <name>
              <surname>Hanson</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Rieger&#x2019;s syndrome: a case report with a 15-year follow-up.</article-title>
          <source>Arch Ophthalmol</source>
          <year>1979</year>
          <volume>97</volume>
          <fpage>2120</fpage>
          <lpage>2</lpage>
          <pub-id pub-id-type="pmid">508179</pub-id>
        </element-citation>
      </ref>
      <ref id="r19">
        <label>19</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Holmberg</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>CY</given-names>
            </name>
            <name>
              <surname>Hjalt</surname>
              <given-names>TA</given-names>
            </name>
          </person-group>
          <article-title>PITX2 gain-of-function in Rieger syndrome eye model.</article-title>
          <source>Am J Pathol</source>
          <year>2004</year>
          <volume>165</volume>
          <fpage>1633</fpage>
          <lpage>41</lpage>
          <pub-id pub-id-type="pmid">15509533</pub-id>
        </element-citation>
      </ref>
      <ref id="r20">
        <label>20</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Priston</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kozlowski</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Gill</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Letwin</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Buys</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Levin</surname>
              <given-names>AV</given-names>
            </name>
            <name>
              <surname>Walter</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>H&#xE9;on</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Functional analyses of two newly identified PITX2 mutants reveal a novel molecular mechanism for Axenfeld-Rieger syndrome.</article-title>
          <source>Hum Mol Genet</source>
          <year>2001</year>
          <volume>10</volume>
          <fpage>1631</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">11487566</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
